Osteoporosis and Tooth Loss After Menopause, the Jawbone Connection Nobody Explains

Osteoporosis gets explained at the hip and the spine, almost never at the jaw. A 2024 study scanned 97 postmenopausal women at 4 sites, the jawbone included, and found jaw density moved in the same direction as hip and spine density every time. That matters because the jawbone is the only thing holding a tooth in its socket. Shilajit sits at the center of a 48-week randomized human trial that measured bone density in postmenopausal women directly, and here is what it showed, along with the hard limit of what it never measured.
Can osteoporosis affect your jawbone too?

The mandible is bone. That sounds obvious written down, and it is still the part of osteoporosis that almost never gets said out loud, because the conversation lives at the hip and the spine where the fractures are dramatic.
Bone is not inert scaffolding. It is torn down by cells called osteoclasts and rebuilt by cells called osteoblasts, continuously, in a cycle called remodeling. Estrogen is one of the main signals restraining the breakdown side of that cycle. When estrogen falls at menopause, breakdown speeds up, rebuilding fails to keep pace, and density drops. That process is systemic. It is not a hip event that the rest of the skeleton sits out.
The jaw sits inside that same system, taking the same signal, running the same remodeling cycle.
Why the jaw is not exempt from what happens at the hip
The part of the mandible that anchors teeth is alveolar bone, and it is unusually active tissue. It remodels in response to the mechanical load of chewing, the same way the hip responds to the load of walking. Active tissue is responsive tissue, which cuts both ways. It rebuilds readily when the signal is intact, and it gives ground quickly when the signal weakens.
The broader research has linked osteoporosis with periodontal alveolar bone loss for decades, and progressive bone loss is a well-established contributor to tooth loss risk in postmenopausal women. What was missing was somebody putting a woman's jaw and her hip on the same scanner on the same day.
What did the jawbone study actually measure?
Duncea and colleagues did exactly that in 2024, publishing in the journal Medicina.
They recruited 97 postmenopausal women. 62 had osteoporosis, mean age 62.4. The remaining 35 served as controls, mean age 56.8. Every woman was scanned by DXA at 4 sites, the lumbar spine from L1 to L4, the femoral neck, the total hip, and the mandible.
Mandibular density came back significantly lower in the osteoporosis group.
Here is how each systemic site tracked against the jawbone measurement.
| Site scanned | Correlation with jawbone density | What the number says |
|---|---|---|
| Lumbar spine, L1 to L4 | r = 0.506, p less than 0.0001 | Strongest of the 3 correlations |
| Femoral neck | r = 0.482, p less than 0.0001 | Close behind the spine |
| Total hip | r = 0.466, p less than 0.0001 | Same direction, same moderate range |
| Mandible | The site being compared | Significantly lower in the osteoporosis group |
Moderate positive correlation is a real finding and a modest one, so it is worth being precise about what it means. The weaker a woman's hip and spine density, the weaker her jawbone density tended to be as well. Tended to be. Not always, and not by any fixed amount.
Where this study is honest about its limits
The authors are careful with their own result, and repeating that care costs us nothing.
- It is cross-sectional, a single snapshot in time, so it cannot establish which decline came first
- Correlation between 2 sites is not evidence that improving one improves the other
- The sample is 97 women in a single country, Romania, not a multi-country population study
- The authors flag unmeasured confounders of their own, including body mass and blood parameters
- DXA at the mandible carries methodology limits the authors name directly, since the jaw was never the site the technique was built around
None of that makes the finding useless. It makes it a signal worth understanding rather than a settled fact worth quoting as proof.
What happens to teeth when the jawbone thins?

A tooth is not attached to your face. It is held in a socket of bone, suspended by a ligament, and the socket is doing the work. When the socket thins, the consequences show up in ways women rarely connect back to a bone scan.
Loose teeth and the speed of tooth loss
A tooth that feels slightly mobile is reporting on the bone around it. Less mineral density in the socket wall means less mechanical grip on the root, which is why a tooth can loosen in a mouth with no new cavities and reasonable hygiene. The tooth is fine. What is holding it is not.
Dentures that stop fitting the way they used to
Dentures are fitted to the ridge of bone left behind after teeth are gone, and that ridge keeps remodeling for the rest of a woman's life. As it resorbs, the fit drifts. Sore spots appear, the seal loosens, and a device that fit beautifully 18 months ago starts slipping at dinner. That is usually read as a denture problem. Underneath, it is often a bone problem.
Why implants depend on the same bone
An implant is a post anchored into the jawbone, and it needs enough density and volume to hold. Thinner bone is why implant plans sometimes turn into grafting plans first. The implant is only ever as stable as the bone it is screwed into.
What has shilajit been shown to do to bone density?
This is where the evidence gets stronger and narrower at the same time.
Pingali and colleagues published a 48-week double-blind randomized controlled trial in 60 postmenopausal women in 2022. At baseline these women had osteopenia at the lumbar spine, with a T-score of -2.0, and osteoporosis at the femoral neck and hip at -2.5, which the paper's own results section names as osteoporosis.
Shilajit raised bone mineral density at both scanned sites, dose-dependently, while the placebo group kept losing bone.
Every single woman in the treatment group reversed her osteoporosis within 6 months. That result was measured at the hip and the spine, which are the sites the trial scanned.
The bone turnover markers explain the mechanism behind the density numbers.
- CTX-1, a marker of bone breakdown, fell 17.7 to 21.8 percent by week 48
- BALP, a marker of bone formation, fell 16.1 to 23.2 percent, the pattern the authors identify as an antiresorptive signature
- RANKL, the signal that recruits bone-dissolving cells, dropped 9.8 percent
- OPG, the decoy protein that blocks RANKL from doing that job, rose 57.3 percent
- Zero side effects were reported across the trial
Two laboratory studies fill in the cellular picture. Kangari and colleagues found shilajit accelerated osteogenic differentiation of human adipose-derived stem cells, raising both alkaline phosphatase activity and calcium deposition, the 2 standard signs of active bone-building cells. Abbasi and colleagues found low-dose mumie, a form of shilajit, raised osteoblast-like cell proliferation at 100 to 200 micrograms per milliliter, while 300 micrograms per milliliter became toxic to the cells. More is not automatically better with any mineral compound.
Shilajit is not a hormone and does not add estrogen to the body. What the mechanism research points to is fulvic acid supporting the body's own estrogen signaling and mineral transport, working alongside a remodeling cycle that is already running.
What the trial did not measure
No shilajit trial has ever measured jawbone or mandibular bone density.
Not one.
Pingali scanned the lumbar spine and the hip, and that is the full extent of what the reversal result covers. The Duncea correlation says jaw density and hip density tend to move together in postmenopausal women. It does not say that raising hip density with anything, shilajit included, raises jaw density or prevents a single tooth from loosening.
That is the honest ceiling. Same systemic bone-density mechanism, an open question at the jaw specifically, and nobody has run the study that would close it.
How does the usual dental approach compare with the bone density research?
Both are looking at the same mouth from opposite ends. Here is the side by side.
| What dental care typically addresses | What the bone density research addresses | |
|---|---|---|
| The target | Plaque, gum inflammation, tooth surface, appliance fit | The mineral density of the bone underneath |
| How it is measured | Visual exam, probing depth, dental X-rays | DEXA scanning and bone turnover markers in blood |
| Timescale | Visit to visit, months apart | Remodeling cycles measured over months to years |
| Evidence involving shilajit | None, no dental trial exists | A 48-week randomized trial at spine and hip |
| Blind spot | Systemic density driving the local problem | The local outcome nobody has scanned yet |
Neither column replaces the other, and framing them as rivals would be dishonest. Good dental care handles what is happening at the surface of the tooth. It was never designed to change the density of the bone holding that tooth in place.
What actually supports jawbone density day to day?

A handful of ordinary habits act on the same remodeling cycle all of this research is measuring.
- Keep chewing real food with texture, since alveolar bone remodels in response to mechanical load the way the hip responds to walking
- Get enough protein and calcium from food first, since both are raw material the rebuilding side of the cycle depends on
- Add weight-bearing movement several times a week, which supports systemic density that the jaw correlates with
- Stop smoking if you smoke, since it accelerates bone loss and periodontal breakdown through 2 separate and well-documented routes
- Know your numbers, since a DEXA scan reports a T-score and the dental X-rays taken at routine cleanings already capture the mandible
Shilajit is the compound behind the bone-density research described above, and it is the core ingredient in Optimum Shilajit, sourced from the Altai mountains and third-party lab tested for purity on every batch by a family-owned company out of Florida. No trial has measured what it does at the jaw, and we would rather say that plainly than imply a result nobody has produced.
Common questions about the jawbone, tooth loss, and shilajit
Can osteoporosis cause tooth loss?
The jawbone is what holds each tooth in its socket, and it is made of the same bone tissue that thins everywhere else after menopause. A 2024 study measured jawbone density directly and found it was significantly lower in postmenopausal women with osteoporosis. Progressive bone loss is a well-established contributor to tooth loss risk, though a correlation between two sites is not the same as proof that one causes the other.
Does a low hip T-score mean your jawbone is weak too?
It raises the odds. Duncea and colleagues found moderate positive correlations between jawbone density and every systemic site they scanned, strongest at the lumbar spine at r equals 0.506. Moderate means the sites move together in general, not that one number predicts the other in any individual woman.
Has shilajit been tested on jawbone density?
No. No shilajit trial has ever measured jawbone or mandibular density. The 48-week randomized trial in postmenopausal women scanned the lumbar spine and the hip only. The jawbone is an open question, and we say that plainly rather than stretch a hip and spine result to cover a site nobody scanned.
Does shilajit add estrogen to the body?
No. Shilajit is not a hormone. What the research points to is fulvic acid supporting the body's own estrogen signaling and mineral transport, working with the bone remodeling cycle already running. Across human shilajit studies, zero serious adverse events have been reported.
How fast did the shilajit bone trial show a change?
The trial ran 48 weeks in 60 postmenopausal women, and bone mineral density had already risen at both scanned sites by the 6-month mark while the placebo group kept losing bone. Every single woman in the treatment group reversed her osteoporosis within 6 months, measured at the hip and spine.
Sources
- Duncea I, Bacali C, Buduru S, Scrobota I, Almasan O. The Association of Systemic and Mandibular Bone Mineral Density in Postmenopausal Females with Osteoporosis. Medicina (Kaunas), 2024;60(8):1313. https://pubmed.ncbi.nlm.nih.gov/39202594/
- Pingali U, et al. Effect of Purified Shilajit on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women. 2022. https://pubmed.ncbi.nlm.nih.gov/35933897/
- Kangari P, et al. Shilajit accelerates osteogenic differentiation of human adipose-derived stem cells. 2022. https://pubmed.ncbi.nlm.nih.gov/36153551/
- Abbasi B, et al. Effect of mumie on MG-63 osteoblast-like cell proliferation. 2019. https://pubmed.ncbi.nlm.nih.gov/31983854/